porfiromycin has been researched along with Malignant Melanoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bradner, WT; Cheng, L; Iyengar, BS; Lin, HJ; Remers, WA | 1 |
| Bradner, WT; Iyengar, BS; Remers, WA; Sami, SM; Schurig, JE | 1 |
2 other study(ies) available for porfiromycin and Malignant Melanoma
| Article | Year |
|---|---|
Development of new mitomycin C and porfiromycin analogues.
Topics: Animals; Antineoplastic Agents; Dose-Response Relationship, Drug; Leukemia, Experimental; Melanoma; Mice; Mitomycins; Neoplasms, Experimental; Porfiromycin; Structure-Activity Relationship | 1981 |
Mitomycin C and porfiromycin analogues with substituted ethylamines at position 7.
Topics: Animals; Ethylamines; Female; Leukemia L1210; Leukemia P388; Leukopenia; Melanoma; Mice; Mitomycins; Neoplasms, Experimental; Porfiromycin; Structure-Activity Relationship | 1983 |